Form D · Pharmaceuticals

SEN-JAM PHARMACEUTICAL INC.

Huntington, NY · CIK 0001802249

Offering snapshot reported Jul 25, 2024 · SEC filing

Reported sold
$295K
Offering amount: $10M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 22, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$148K$295KJul 12, 2023: $80,000.00Jul 12, 2023Jul 25, 2024: $295,000.00Jul 25, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$80,000 → $295,000
  • Reported investors2 → 6
  • Minimum accepted$10,000 → $0

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 25, 2024Amendment$295,000$215,000vs Jul 12, 20236SEC filing
Jul 12, 2023Initial$80,000No comparison2SEC filing
Jun 2, 2020Amendment$185,000$185,000vs Feb 5, 20205SEC filing
Feb 5, 2020Initial$0No comparison2SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired, Other
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-486575
The total amount sold and number of investors reflects sales to only residents of the United States.
Convertible Promissory Notes; Warrants to purchase shares of common stock; Shares of common stock.

Source: Form D, filed Jul 25, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Iversen Director, Executive
Jacqueline Iversen Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
223 Wall Street, #130
Huntington, NY, 11743